A novel early chorioallantoic membrane assay demonstrates quantitative and qualitative changes caused by antiangiogenic substances

Journal of Laboratory and Clinical Medicine

Volumn 141, Issue 3, 2003, Pages 217-228

  Hazel, Susan J ^a,b  

^a INSTITUTE OF MEDICAL AND VETERINARY SCIENCE   (Australia)

^b NONE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMILORIDE; ANGIOGENESIS INHIBITOR; FUMAGILLIN; PI 88; SU 5614; SURAMIN; UNCLASSIFIED DRUG;

ANGIOGENESIS; ARTICLE; CHORIOALLANTOIS; DRUG ACTIVITY; IMAGING; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; REPRODUCIBILITY;

EID: 0037342311     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1067/mlc.2003.19     Document Type: Article

References (43)

1. Ribatti D, Nico B, Vacca A, Roncali L, Burri PH, Djonov V. Chorioallantoic membrane capillary bed: a useful target for studying angiogenesis and anti-angiogenesis in vivo. Anat Rec 2001;264:317-24.
2. Ausprunk DH, Knighton DR, Folkman J. Differentiation of vascular endothelium in the chick chorioallantois: a structural and autoradiographic study. Dev Biol 1974;38:237-48.
3. Ribatti D, Gualandris A, Bastai M, Vacca A, Iurlaro M, Roncali L, et al. New model for the study of angiogenesis and antiangiogenesis in the chick embryo chorioallantoic membrane: the gelatin sponge/chorioallantoic membrane assay. J Vasc Res 1997;34:455-63.
4. Hatton MW, Day S, Southward SM, Dereske M, Ross B, Seidlitz E, et al. Metabolism of rabbit angiostatin glycoforms I and II in rabbits: angiostatin I leaves the intravascular space faster and appears to have greater anti-angiogenic activity than angiostatin II. J Lab Clin Med 2001;138:83-93.
5. O'Reilly MS, Holmgren L, Shing Y, Chert C, Rosenthal RA, Moses M, et al. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 1994;79:315-28.
6. van der Schaft DWJ, Toebes EAH, Haseman JR, Mayo KH, Griffioen AW. Bactericidal/permeability-increasing protein (BPI) inhibits angiogenesis via induction of apoptosis in vascular endothelial cells. Blood 2000;96:176-81.
7. Dixelius J, Larsson H, Sasaki T, Holmqvist K, Lu L, Engstrom A. et al. Endostatin-induced tyrosine kinase signaling through the Shb adaptor protein regulates endothelial cell apoptosis. Blood 2000;95:3403-11.
8. Pipili-Synetos E, Papageorgiou A, Sakkoula E, Sotiropoulou G, Fotsis T, Karakiulakis G, et al. Inhibition of angiogenesis, tumour growth and metastasis by the NO-releasing vasodilators, isosorbide mononitrate and dinitrate. Br J Pharmacol 1995;116:1829-34.
9. Parsons-Wingerter P, Lwai B, Yang MD, Elliot KE, Milaninia A, Redlitz A, et al. A novel assay of angiogenesis in the quail chorioallantoic membrane: stimulation by bFGF and inhibition by angiostatin according to fractal dimension and grid intersection. Microvasc Res 1998;55:201-14.
10. Sun L, Tran N, Tang F, App H, Hirth P, McMahon G, et al. Synthesis and biological evaluations of 3-substituted indolin-2-ones: a novel class of tyrosine kinase inhibitors that exhibit selectivity toward particular receptor tyrosine kinases. J Med Chem 1998;41:2588-603.
11. Waltenberger J, Mayr U, Frank H, Hombach V. Suramin is a potent inhibitor of vascular endothelial growth factor: a contribution to the molecular basis of its antiangiogenic action. J Mol Cell Cardiol 1996;28:1523-9.
12. Zugmaier G, Favoni R, Jaeger R, Rosen N, Knabbe C. Polysulfated heparinoids selectively inactivate heparin-binding angiogenesis factors. Ann N Y Acad Sci 1999;886:243-8.
13. Mahoney CW, Azzi A, Huang KP. Effects of suramin, an anti-human immunodeficiency virus reverse transcriptase agent, on protein kinase C: differential activation and inhibition of protein kinase C isozymes. J Biol Chem 1990;265:5424-8.
14. Nakajima M, DeChavigny A, Johnson CE, Hamada J, Stein CA, Nicolson GL. Suramin: a potent inhibitor of melanoma heparanase and invasion. J Biol Chem 1991;266:9661-6.
15. Abe J, Zhou W, Takuwa N, Taguchi J, Kurokawa K, Kumada M, et al. A fumagillin derivative angiogenesis inhibitor, AGM-1470, inhibits activation of cyclin-dependent kinases and phosphorylation of retinoblastoma gene product but not protein tyrosyl phosphorylation or protooncogene expression in vascular endothelial cells. Cancer Res 1994;54:3407-12.
16. Sin N, Meng L, Wang MQ, Wen JJ, Bornmann WG, Crews CM. The anti-angiogenic agent fumagillin covalently binds and inhibits the methionine aminopeptidase, MetAP-2. Proc Natl Acad Sci U S A 1997;94:6099-103.
17. Knoll A, Schmidt S, Chapman M, Wiley D, Bulgrin J, Blank J, et al. A comparison of two controlled-release delivery systems for the delivery of amiloride to control angiogenesis. Microvasc Res 1999;58:1-9.
18. Parish CR, Freeman C, Brown KJ, Francis DJ, Cowden WB. Identification of sulfated oligosaccharide-based inhibitors of tumor growth and metastasis using novel in vitro assays for angiogenesis and heparanase activity. Cancer Res 1999;59:3433-41.
19. Dugan JD, Lawton MT, Glaser B, Brem H. A new technique for explanation and in vitro cultivation of chicken embryos. Anat Rec 1991;229:125-8.
20. Dunn BE, Fitzharris TP, Barnett BD. Effects of varying chamber construction and embryo pre-incubation age on survival and growth of chick embryos in shell-less culture. Anat Rec 1981;199:33-43.
21. Sells PG, Richards AM, Laing GD, Theakston RD. The use of hens' eggs as an alternative to the conventional in vivo rodent assay for antidotes to haemorrhagic venoms. Toxicon 1997;35:1413-21.
22. Rizzo V, Kim D, Duran WN, DeFouw DO. Ontogeny of microvascular permeability to macromolecules in the chick chorioallantoic membrane during normal angiogenesis. Microvasc Res 1995;49:49-63.
23. Melkonian G, Munoz N, Chung J, Tong C, Marr R, Talbot P. Capillary plexus development in the day five to day six chick chorioallantoic membrane is inhibited by cytochalasin D and suramin. J Exp Zool 2002;292:241-54.
24. Danesi R, Del BD, Soldani P, Campagni A, La RRV, Myers CE, et al. Suramin inhibits bFGF-induced endothelial cell proliferation and angiogenesis in the chick chorioallantoic membrane. Br J Cancer 1993;68:932-8.
25. Ausprunk DH. Distribution of hyaluronic acid and sulfated glycosaminoglycans during blood-vessel development in the chick chorioallantoic membrane. Am J Anat 1986;177:313-31.
26. Veikkola T, Karkkainen M, Claesson-Welsh L, Alitalo K. Regulation of angiogenesis via vascular endothelial growth factor receptors. Cancer Res 2000;60:203-12.
27. Wilting J, Eichmann A, Christ B. Expression of the avian VEGF receptor homologues Quek1 and Quek2 in blood-vascular and lymphatic endothelial and non-endothelial cells during quail embryonic development. Cell Tissue Res 1997;288:207-23.
28. Schmidt M, Flamme I. The in vivo activity of vascular endothelial growth factor isoforms in the avian embryo. Growth Factors 1998;15:183-97.
29. Flamme I, Schulze-Osthoff K, Jacob HJ. Mitogenic activity of chicken chorioallantoic fluid is temporally correlated to vascular growth in the chorioallantoic membrane and related to fibroblast growth factors. Development 1991;111:683-90.
30. Ribatti D, Urbinati C, Nico B, Rusnati M, Roncali L, Presta M. Endogenous basic fibroblast growth factor is implicated in the vascularization of the chick embryo chorioallantoic membrane. Dev Biol 1995;170:39-49.
31. Parsons-Wingerter P, Elliot KE, Clark JI, Farr AG. Fibroblast growth factor-2 selectively stimulates angiogenesis of small vessels in arterial tree. Arterioscler Thromb Vasc Biol 2000;20:1250-6.
32. Bikfalvi A, Klein S, Pintucci G, Rifkin DB. Biological roles of fibroblast growth factor-2. Endocr Rev 1997;18:26-45.
33. Olivo M, Bhardwaj R, Schulze-Osthoff K, Sorg C, Jacob HJ, Flamme I. A comparative study on the effects of tumor necrosis factor-a (TNF-a), human angiogenic factor (h-AF) and basic fibroblast growth factor (bFGF) on the chorioallantoic membrane of the chick embryo. Anat Rec 1992;234:105-15.
34. Ribatti D, Vacca A, Giacchetta F, Cesaretti S, Anichini M, Roncali L, et al. Lipoprotein (a) induces angiogenesis on the chick embryo chorioallantoic membrane. Eur J Clin Invest 1998;28:533-7.
35. Bernardini G, Spinetti G, Ribatti D, Camarda G, Morbidelli L, Ziche M, et al. I-309 binds to and activates endothelial cell functions and acts as an angiogenic molecule in vivo. Blood 2000;96:4039-45.
36. Dusseau JW, Hutchins PM, Malbasa DS. Stimulation of angiogenesis by adenosine on the chick chorioallantoic membrane. Circ Res 1986;59:163-70.
37. Adams RH, Wilkinson GA, Weiss C, Diella F, Gale NW, Deutsch U, et al. Roles of ephrinB ligands and EphB receptors in cardiovascular development: demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis. Gene Dev 1999;13:295-306.
38. Wang HU, Chen Z-F, Anderson DJ. Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4. Cell 1998;93:741-53.
39. Herzog Y, Kalcheim C, Kahane N, Reshef R, Neufeld G. Differential expression of neuropilin-1 and neuropilin-2 in arteries and veins. Mech Dev 2001;109:115-9.
40. Mukouyama Y, Shin D, Britsch S, Taniguchi M, Anderson DJ. Sensory nerves determine the pattern of arterial differentiation and blood vessel branching in the skin. Cell 2002;109:693-705.
41. Guyton AC. Physics of blood: blood flow, and pressure: Hemodynamics. In: Guyton AC, Hall JE, eds. Textbook of medical physiology. Philadelphia: Saunders, 1981:206-18.
42. Meyers MO, Gagliardi AR, Flattmann GJ, Su JL, Wang Y-Z, Woltering EA. Suramin analogs inhibit human angiogenesis in Vitro. J Surg Res 2000;91:130-4.
43. Alliegro MC, Alliegro MA, Cragoe EJ Jr, Glaser BM. Amiloride inhibition of angiogenesis in vitro. J Exp Zool 1993;267:245-52.